February 2026
Create an account to continue using Similarweb
View website metrics, keywords, top marketing channels, market research tools, and more.
Create your free accountlunsumio.com
Showing Similarweb estimated data.
Publicly validate your site’s metrics by connecting your GA4
Reflect your success
Verify your website's traffic and engagement metrics by connecting to Google Analytics
Bounce Rate
52%
Pages per Visit
1.49
Avg Visit Duration
00:00:21
- Company
- - -
- Industry
- - -
Top 10 lunsumio.com Competitors
The Top 10 Sites Like lunsumio.com in February 2026 are ranked by their affinity to lunsumio.com in terms of keyword traffic, audience targeting, and market overlap
Access our presentations, publications, and more to see how we’re unlocking the full potential of precision genomics.
- Company
- - -
- Industry
- - -
Global Rank
#3,642,571
599,634Bounce Rate
50.83%
Pages per Visit
1.58
Avg Visit Duration
00:00:12
Similarity Score
100%Breyanzi® (lisocabtagene maraleucel) CAR T cell therapy treatment is used to treat adult patients with relapsed/refractory large B-cell lymphoma (LBCL). Please see full Prescribing Information, including Boxed WARNINGS and Medication Guide.
- Company
- - -
- Industry
- - -
Global Rank
#839,175
172,576Bounce Rate
62.7%
Pages per Visit
1.61
Avg Visit Duration
00:00:47
Similarity Score
98%Learn about how YESCARTA® (axicabtagene ciloleucel) works. See full Prescribing Information, including BOXED WARNING.
- Company
- - -
- Industry
- - -
Bounce Rate
74.95%
Pages per Visit
1.35
Avg Visit Duration
00:00:52
Similarity Score
95%Recommended dosing for TAZVERIK® (tazemetostat), an oral, twice-daily tablet for patients with advanced epithelioid sarcoma. Avoid coadministration of strong or moderate CYP3A inhibitors with TAZVERIK. If coadministration of strong or moderate CYP3A inhibitors cannot be avoided, reduce TAZVERIK dose. Avoid coadministration of moderate or strong CYP3A inducers with TAZVERIK, which may decrease the efficacy of TAZVERIK. Coadministration of TAZVERIK with CYP3A substrates, including hormonal contraceptives, can result in decreased concentrations and reduced efficacy of CYP3A substrates. See Important Safety Information and full Prescribing Information, including Medication Guide.
- Company
- - -
- Industry
- - -
Bounce Rate
36.21%
Pages per Visit
1.47
Avg Visit Duration
00:00:07
Similarity Score
93%Find a list of questions to start a conversation with your doctor about POLIVY® (polatuzumab vedotin-piiq) plus R-CHP and DLBCL. See full safety information.
- Company
- - -
- Industry
- - -
Bounce Rate
87.96%
Pages per Visit
1.32
Avg Visit Duration
00:00:11
Similarity Score
92%Learn about lupus nephritis, its causes, symptoms, and how GAZYVA® (obinutuzumab) may help. Explore resources for patients and caregivers. See Important Safety Information including Serious Side Effects for more information.
- Company
- - -
- Industry
- - -
Global Rank
#895,234
382,975Bounce Rate
86.16%
Pages per Visit
1.16
Avg Visit Duration
00:00:23
Similarity Score
89%Learn more about Herceptin® (trastuzumab) by contacting the Herceptin Financial Support Team. See Full Safety including Boxed Warnings for more information.
- Company
- - -
- Industry
- - -
Global Rank
#2,481,674
200,291Bounce Rate
44.91%
Pages per Visit
1.59
Avg Visit Duration
00:00:18
Similarity Score
88%Learn about the financial assistance options for people taking Itovebi® (inavolisib), including for those who don't have insurance. See full safety for more information.
- Company
- - -
- Industry
- - -
Bounce Rate
86.38%
Pages per Visit
1.21
Avg Visit Duration
00:01:01
Similarity Score
86%Here to help patients get access to JELMYTO
- Company
- - -
- Industry
- - -
Bounce Rate
19.93%
Pages per Visit
2.40
Avg Visit Duration
00:00:16
Similarity Score
85%learn about kisqali, a cdk4/6 inhibitor used to treat hr+/her2- metastatic breast cancer and early breast cancer. see full prescribing & safety info
- Company
- - -
- Industry
- - -
Global Rank
#1,051,142
690,792Bounce Rate
77.57%
Pages per Visit
1.28
Avg Visit Duration
00:00:16
Similarity Score
84%lunsumio.com's top 5 competitors in February 2026 are: foresight-dx.com, breyanzi.com, yescartahcp.com, tazverik.com, and more.
According to Similarweb data of monthly visits, lunsumio.com’s top competitor in February 2026 is foresight-dx.com. lunsumio.com 2nd most similar site is breyanzi.com, and closing off the top 3 is yescartahcp.com.
tazverik.com ranks as the 4th most similar website to lunsumio.com and polivy.com ranks fifth in February 2026.
The other five competitors in the top 10 list are gazyva.com, herceptin.com, itovebi.com, jelmyto.com, and kisqali-hcp.com.